Combined inhibition of MCL1 and BCL-2 with AMG 176 and venetoclax induces anti-tumor effects in primary patient samples and models of acute myeloid leukemia

被引：0
|
作者：
Caenepeel, Sean R. [1 ]
Osgood, Tao [1 ]
Belmontes, Brian [1 ]
Sun, Jan [1 ]
Cajulis, Elaina [1 ]
Wei, Andrew [2 ]
Coxon, Angela [1 ,3 ]
Canon, Jude [1 ]
Hughes, Paul [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
[2] Alfred Hosp, Melbourne, Vic, Australia
[3] Monash Univ, Melbourne, Vic, Australia
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-3972
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3972
引用
收藏
页数：2
相关论文
共 40 条
  • [31] Acute myeloid leukemia possessing jumping translocation is related to highly elevated levels of EAT/mcl-1, a Bcl-2 related gene with anti-apoptotic functions
    Okita, H
    Umezawa, A
    Fukuma, M
    Ando, T
    Urano, F
    Sano, M
    Nakata, Y
    Mori, T
    Hata, J
    LEUKEMIA RESEARCH, 2000, 24 (01) : 73 - 77
  • [32] BCL-2 inhibitor APG-2575 and homoharringtonine (HHT) synergistically induces apoptosis and inhibits tumor growth in preclinical models of acute myeloid leukemia and myelodysplastic syndromes (AML/MDS).
    Fang, Douglas D.
    Tang, Qiuqiong
    Kong, Yanhui
    Rong, Tao
    Wang, Qixin
    Deng, Jing
    Yang, Dajun
    Zhai, Yifan
    CANCER RESEARCH, 2021, 81 (13)
  • [33] Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics (vol 13, 57, 2023)
    Carter, Bing Z.
    Mak, Po Yee
    Tao, Wenjing
    Ayoub, Edward
    Ostermann, Lauren B.
    Huang, Xuelin
    Loghavi, Sanam
    Boettcher, Steffen
    Nishida, Yuki
    Ruvolo, Vivian
    Hughes, Paul E.
    Morrow, Phuong K.
    Haferlach, Torsten
    Kornblau, Steven
    Muftuoglu, Muharrem
    Andreeff, Michael
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [34] FLT3 inhibition by olverembatinib (HQP1351) downregulates MCL-1 and synergizes with BCL-2 inhibitor lisaftoclax (APG-2575) in preclinical models of FLT3-ITD mutant acute myeloid leukemia
    Fang, Douglas D.
    Zhu, Hengrui
    Tang, Qiuqiong
    Wang, Guangfeng
    Min, Ping
    Wang, Qixin
    Li, Na
    Yang, Dajun
    Zhai, Yifan
    TRANSLATIONAL ONCOLOGY, 2022, 15 (01):
  • [35] Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model
    Carter, Bing Z.
    Mak, Po Yee
    Tao, Wenjing
    Ostermann, Lauren B.
    Mak, Duncan H.
    Ke, Baozhen
    Ordentlich, Peter
    Mcgeehan, Gerard M.
    Andreeff, Michael
    REVISTA CHILENA DE LITERATURA, 2023, (108): : 2513 - 2519
  • [36] Inhibition of BCL-2 with liposomal delivered antisense oligonucleotides (AS-ODN) induces apoptosis and increases the sensitivity of primary acute myeloid leukemia (AML) cells nod cell lines to cytosine arabinoside and doxorubicin.
    Konopleva, M
    Tari, A
    LopezBerestein, G
    Andreeff, M
    BLOOD, 1997, 90 (10) : 2200 - 2200
  • [37] Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model
    Carter, Bing Z.
    Mak, Po Yee
    Tao, Wenjing
    Ostermann, Lauren B.
    Mak, Duncan H.
    Ke, Baozhen
    Ordentlich, Peter
    McGeehan, Gerard M.
    Andreeff, Michael
    HAEMATOLOGICA, 2023, 108 (09) : 2513 - 2519
  • [38] FMS-like tyrosine kinase 3 (FLT3) inhibition by olverembatinib (HQP1351) downregulates MCL-1 and synergizes with BCL-2 inhibitor APG-2575 in preclinical models of FLT3-mutant acute myeloid leukemia (AML)
    Fang, Douglas D.
    Zhu, Hengrui
    Tang, Qiuqiong
    Wang, Qixin
    Li, Na
    Fang, Xu
    Min, Ping
    Wang, Guangfeng
    Yang, Dajun
    Zhai, Yifan
    CANCER RESEARCH, 2021, 81 (13)
  • [39] The Effects of Resveratrol, Gallic Acid, and Piperine on the Expression of miR-17, miR-92b, miR-181a, miR-222, BAX, BCL-2, MCL-1, WT1, c-Kit, and CEBPA in Human Acute Myeloid Leukemia Cells and Their Roles in Apoptosis
    Saadi, Mahdiyar Iravani
    Moayedi, Javad
    Hosseini, Fakhroddin
    Rostamipour, Hossain Ali
    Karimi, Zahed
    Rahimian, Zahra
    Ahmadyan, Maryam
    Ghahramani, Zahra
    Dehghani, Mehdi
    Yousefi, Karim
    Kheradmand, Nadiya
    Ramzi, Mani
    Fooladivanda, Nastaran
    BIOCHEMICAL GENETICS, 2023, 62 (4) : 2958 - 2974
  • [40] Combined Pharmacologic Inhibition of Bcl-Xl/Bcl-2 and mTORC1/2 Survival Signals Trigger Apoptosis in BCR-ABL1+ in Vitro Models of Blast Crisis Chronic Myelogenous Leukemia (CML-BC), and Primary CD34+/CD38- Stem and CD34+ progenitor Cells From CML-BC Patients
    Harb, Jason G.
    Neviani, Paolo
    Huettner, Claudia S.
    Marcucci, Guido
    Perrotti, Danilo
    BLOOD, 2011, 118 (21) : 1177 - 1178
1234